Featured Research

from universities, journals, and other organizations

Genetic predisposition to certain skin cancers may be associated with vitamin D deficiency

Date:
October 20, 2010
Source:
JAMA and Archives Journals
Summary:
Patients with basal cell nevus syndrome, which predisposes them to develop non-melanoma skin cancers, appear to be at increased risk for vitamin D deficiency if they take steps to protect themselves from sunlight, according to a new study.

Patients with basal cell nevus syndrome, which predisposes them to develop non-melanoma skin cancers, appear to be at increased risk for vitamin D deficiency if they take steps to protect themselves from sunlight, according to a report in the October issue of Archives of Dermatology, one of the JAMA/Archives journals.

"Vitamin D deficiency has been associated with an increased risk of autoimmune disease, fractures, cancer, cardiovascular disease and all-cause mortality," the authors write as background information in the article. "There is increasing concern that sun protection, recommended by dermatologists to prevent further UV damage in populations susceptible to skin cancer, may result in abnormally low levels of 25-hydroxyvitamin D [25(OH)D, a blood measure of vitamin D levels], which may have subsequent detrimental effects on health."

Jean Y. Tang, M.D., Ph.D., of Stanford University Medical Center, Redwood City, Calif., and colleagues studied 41 patients with basal cell nevus syndrome, who are genetically predisposed to develop basal cell carcinomas. Individuals with this condition usually develop multiple basal cell carcinomas in young adulthood, as opposed to most cases of sporadic basal cell carcinoma, which occur in the sixth to seventh decades of life. Patients with basal cell nevus syndrome generally try to prevent skin cancers by using sunscreen and avoiding the sun during peak hours.

The 41 patients had blood drawn an average of three times during the two-year study; 23 (56 percent) were vitamin D deficient. When compared with the general population, patients with basal cell nevus syndrome had lower average vitamin D levels and were three times more likely to be deficient.

Blood vitamin D levels were lower among patients with basal cell nevus syndrome who were overweight, and in those who had blood collected in the winter compared with the summer.

Among 35 patients with basal cell nevus syndrome who completed a survey, 28 (80 percent) reported using sunscreen daily and most reported avoiding sunshine during the hours of 10 a.m. and 2 p.m. "It may not be surprising that patients with a genetic predisposition to sun-induced cancers report a high frequency of photoprotection and may be vitamin D deficient," the authors write. "However, the magnitude of this deficiency and the possible additive effect of obesity, which is common in these patients, make individuals with basal cell nevus syndrome optimal candidates for cholecalciferol supplementation."

"Furthermore, if the mechanism for the association between low 25(OH)D levels in patients with basal cell nevus syndrome is indeed photoprotection, these results may be applicable to patients without basal cell nevus syndrome who have sporadic basal cell carcinomas and for whom photoprotection is currently recommended," they conclude. "Given that sporadic basal cell carcinoma is the most common cancer worldwide with more than 1 million cases reported annually in the United States and that most patients with basal cell carcinoma survive for many years after their diagnosis, screening for vitamin D deficiency may become an important part of the care of this population."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jean Y. Tang; Angela Wu; Eleni Linos; Neeta Parimi; Wayne Lee; Michelle Aszterbaum; Maryam M. Asgari; David R. Bickers; Ervin H. Epstein, Jr. High Prevalence of Vitamin D Deficiency in Patients With Basal Cell Nevus Syndrome. Arch Dermatol, 2010; 146 (10): 1105-1110 DOI: 10.1001/archdermatol.2010.247

Cite This Page:

JAMA and Archives Journals. "Genetic predisposition to certain skin cancers may be associated with vitamin D deficiency." ScienceDaily. ScienceDaily, 20 October 2010. <www.sciencedaily.com/releases/2010/10/101018162934.htm>.
JAMA and Archives Journals. (2010, October 20). Genetic predisposition to certain skin cancers may be associated with vitamin D deficiency. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2010/10/101018162934.htm
JAMA and Archives Journals. "Genetic predisposition to certain skin cancers may be associated with vitamin D deficiency." ScienceDaily. www.sciencedaily.com/releases/2010/10/101018162934.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins